Find Vorapaxar Sulfate manufacturers, exporters & distributors on PharmaCompass

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Virtual Booth

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

6 API Suppliers, 1 USDMF, 5 Listed Suppliers, $ API Reference Price

6 API Suppliers
1 USDMF
5 Listed Suppliers
$ API Reference Price

INTERMEDIATES

2 Intermediates Suppliers

2 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

4 FDF Dossiers, 1 FDA Orange Book, 3 Europe

4 FDF Dossiers
1 FDA Orange Book
3 Europe

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 2 DKSH, 4 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 10 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 BASF, 5 DFE Pharma, 5 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 17 Kerry, 10 Microlex e.U, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 4 Pluviaendo, 3 Prachin Chemical, 10 Roquette, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

47 Fillers, Diluents & Binders, 23 Direct Compression, 15 Disintegrants & Superdisintegrants, 15 Granulation, 12 Co-Processed Excipients, 11 Thickeners and Stabilizers, 10 Lubricants & Glidants, 8 Coating Systems & Additives, 7 Controlled & Modified Release, 6 Solubilizers, 5 Film Formers & Plasticizers, 3 Parenteral, 3 Taste Masking, 2 Coloring Agents, 2 Rheology Modifiers, 2 Chewable & Orodispersible Aids, 1 Emulsifying Agents

excipientsByApplications
47 Fillers, Diluents & Binders
23 Direct Compression
15 Disintegrants & Superdisintegrants
15 Granulation
12 Co-Processed Excipients
11 Thickeners and Stabilizers
10 Lubricants & Glidants
8 Coating Systems & Additives
7 Controlled & Modified Release
6 Solubilizers
5 Film Formers & Plasticizers
3 Parenteral
3 Taste Masking
2 Coloring Agents
2 Rheology Modifiers
2 Chewable & Orodispersible Aids
1 Emulsifying Agents

DIGITAL CONTENT

5 NEWS #PharmaBuzz

media
5 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 2 Finished Drug Prices

globalSalesInformation
1 US Medicaid Prescriptions
2 Finished Drug Prices

MARKET PLACE

2 APIs

marketPlace
2 APIs

PATENTS & EXCLUSIVITIES

2 US Patents, 2 Health Canada Patents

patents
2 US Patents
2 Health Canada Patents

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 845,040

MARKET PLACE

API

FDF

2INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

811,945

Annual Reports (USD Million)

Finished Drug Prices

108 RELATED EXCIPIENT COMPANIES

172EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 705260-08-8, Zontivity, Sch 530348, Vorapaxar sulfate [usan], Vorapaxar monosulfate, Chebi:83314

Molecular Formula

C₂₉H₃₅FN₂O₈S

Molecular Weight

590.7 g/mol

InChI Key

NQRYCIGCIAWEIC-CKLVGUEFSA-N

FDA UNII

IN66038E6C

1 2D Structure

Vorapaxar Sulfate

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

ethyl N-[(1R,3aR,4aR,6R,8aR,9S,9aS)-9-[(E)-2-[5-(3-fluorophenyl)pyridin-2-yl]ethenyl]-1-methyl-3-oxo-3a,4,4a,5,6,7,8,8a,9,9a-decahydro-1H-benzo[f][2]benzofuran-6-yl]carbamate;sulfuric acid

2.1.2 InChI

InChI=1S/C29H33FN2O4.H2O4S/c1-3-35-29(34)32-23-10-11-24-20(14-23)15-26-27(17(2)36-28(26)33)25(24)12-9-22-8-7-19(16-31-22)18-5-4-6-21(30)13-18;1-5(2,3)4/h4-9,12-13,16-17,20,23-27H,3,10-11,14-15H2,1-2H3,(H,32,34);(H2,1,2,3,4)/b12-9+;/t17-,20+,23-,24-,25+,26-,27+;/m1./s1

2.1.3 InChI Key

NQRYCIGCIAWEIC-CKLVGUEFSA-N

2.1.4 Canonical SMILES

CCOC(=O)NC1CCC2C(C1)CC3C(C2C=CC4=NC=C(C=C4)C5=CC(=CC=C5)F)C(OC3=O)C.OS(=O)(=O)O

2.1.5 Isomeric SMILES

CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@@H]3[C@H]([C@H]2/C=C/C4=NC=C(C=C4)C5=CC(=CC=C5)F)[C@H](OC3=O)C.OS(=O)(=O)O

2.2 Other Identifiers

2.2.1 UNII

IN66038E6C

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Sch 530348

2. Sch-530348

3. Sch530348

4. Vorapaxar

5. Zontivity

2.3.2 Depositor-Supplied Synonyms

1. 705260-08-8

2. Zontivity

3. Sch 530348

4. Vorapaxar Sulfate [usan]

5. Vorapaxar Monosulfate

6. Chebi:83314

7. In66038e6c

8. Vorapaxar (sulfate)

9. Ethyl N-[(1r,3ar,4ar,6r,8ar,9s,9as)-9-[(e)-2-[5-(3-fluorophenyl)pyridin-2-yl]ethenyl]-1-methyl-3-oxo-3a,4,4a,5,6,7,8,8a,9,9a-decahydro-1h-benzo[f][2]benzofuran-6-yl]carbamate;sulfuric Acid

10. Unii-in66038e6c

11. Zontivity (tn)

12. Carbamic Acid, N-((1r,3ar,4ar,6r,8ar,9s,9as)-9-((1e)-2-(5-(3-fluorophenyl)-2-pyridinyl)ethenyl)dodecahydro-1-methyl-3-oxonaphtho(2,3-c)furan-6-yl)-, Ethyl Ester, Sulfate (1:1)

13. Carbamic Acid, N-[(1r,3ar,4ar,6r,8ar,9s,9as)-9-[(1e)-2-[5-(3-fluorophenyl)-2-pyridinyl]ethenyl]dodecahydro-1-methyl-3-oxonaphtho[2,3-c]furan-6-yl]-, Ethyl Ester, Sulfate (1:1)

14. Sch 530348 Sulfate

15. Vorapaxar Sulfate [mi]

16. Vorapaxar Sulfate (jan/usan)

17. Vorapaxar Sulfate [jan]

18. Chembl2107386

19. Dtxsid60990731

20. Vorapaxar Sulfate [vandf]

21. Sch 530348 H2so4 Salt

22. Vorapaxar Sulfate [who-dd]

23. Amy32612

24. Ex-a1149

25. Hy-10119a

26. Mfcd16038877

27. Akos030524402

28. Vorapaxar Sulfate [orange Book]

29. As-35235

30. Ethyl ((1r,3ar,4ar,6r,8ar,9s,9as)-9-((e)-2-(5-(3-fluorophenyl)pyridin-2-yl)vinyl)-1-methyl-3-oxododecahydronaphtho[2,3-c]furan-6-yl)carbamate Sulfate

31. Cs-0002462

32. D09766

33. Sch 530348 Sulfate; Vorapaxar Sulfate; Mk5348

34. Q27156749

35. 2-[(e)-2-{(3r,3as,4s,4ar,7r,8ar,9ar)-7-[(ethoxycarbonyl)amino]-3-methyl-1-oxododecahydronaphtho[2,3-c]furan-4-yl}ethenyl]-5-(3-fluorophenyl)pyridinium Hydrogen Sulfate

36. Carbamic Acid, ((1r,3ar,4ar,6r,8ar,9s,9as)-9-((1e)-2-(5-(3-fluorophenyl)-2-pyridinyl)ethenyl)dodecahydro-1-methyl-3-oxonaphtho(2,3-c)furan-6-yl)-, Ethyl Ester, Sulfate

37. Carbamic Acid, ((1r,3ar,4ar,6r,8ar,9s,9as)-9-((1e)-2-(5-(3-fluorophenyl)-2-pyridinyl)ethenyl)dodecahydro-1-methyl-3-oxonaphtho(2,3-c)furan-6-yl)-, Ethyl Ester, Sulfate (1:1)

38. Ethyl ((1r,3ar,4ar,6r,8ar,9s,9as)-9-((1e)-2-(5-(3-fluorophenyl)pyridin-2-yl)ethenyl)-1-methyl-3-oxododecahydronaphtho(2,3-c)furan-6-yl)carbamate Sulfate

39. Ethyl [(1r,3ar,4ar,6r,8ar,9s,9as)-9-{(e)-2-[5-(3-fluorophenyl)pyridin-2-yl]ethenyl}-1-methyl-3-oxododecahydronaphtho[2,3-c]furan-6-yl]carbamate Sulfate

2.4 Create Date

2006-10-25

3 Chemical and Physical Properties

Molecular Formula	C₂₉H₃₅FN₂O₈S
Molecular Weight	590.7 g/mol
Hydrogen Bond Donor Count	3
Hydrogen Bond Acceptor Count	10
Rotatable Bond Count	6
Exact Mass	590.20981541 g/mol
Monoisotopic Mass	590.20981541 g/mol
Topological Polar Surface Area	161 Å²
Heavy Atom Count	41
Formal Charge	0
Complexity	902
Isotope Atom Count	0
Defined Atom Stereocenter Count	7
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	1
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	2

4 Drug and Medication Information

4.1 Drug Indication

Zontivityis indicated for the reduction of atherothrombotic events in adult patients with

- a history of myocardial infarction (MI), ,co-administered with acetylsalicylic acid (ASA) and, where appropriate, clopidogrel; or

- symptomatic peripheral arterial disease

(PAD), co-administered with acetylsalicylic acid (ASA) or, where appropriate, clopidogrel.

5 Pharmacology and Biochemistry

5.1 MeSH Pharmacological Classification

Platelet Aggregation Inhibitors

Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)

5.2 ATC Code

B01

API SUPPLIERS